Champions Oncology, Inc. (CSBR)
USD 6.91
(7.97%)
USD 6.91
(7.97%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 50.15 Million | 53.87 Million | 49.1 Million | 41.04 Million | 32.12 Million | 27.06 Million |
| Cost of Revenue | 29.4 Million | 29.53 Million | 23.63 Million | 21.47 Million | 16.88 Million | 14.26 Million |
| Gross Profit | 20.75 Million | 24.33 Million | 25.47 Million | 19.56 Million | 15.24 Million | 12.8 Million |
| Operating Expenses | 28.11 Million | 28.78 Million | 24.87 Million | 19.22 Million | 16.7 Million | 12.53 Million |
| Selling, General and Administrative Expenses | 18.13 Million | 17.24 Million | 15.49 Million | 12.03 Million | 10.85 Million | 7.73 Million |
| Research and Development Expenses | 9.54 Million | 11.54 Million | 9.37 Million | 7.19 Million | 5.85 Million | 4.79 Million |
| Other Expenses | 435 Thousand | -11 Thousand | -24 Thousand | 71 Thousand | -42 Thousand | -39 Thousand |
| Cost and Expenses | 57.51 Million | 58.31 Million | 48.5 Million | 40.7 Million | 33.59 Million | 26.79 Million |
| Operating Income | -7.35 Million | -4.44 Million | 607 Thousand | 338 Thousand | -1.46 Million | 270 Thousand |
| Interest Expense | - | - | 24 Thousand | - | - | 39 Thousand |
| Income Tax Expense | -32 Thousand | 68 Thousand | 35 Thousand | 75 Thousand | 130 Thousand | 103 Thousand |
| Earnings before Tax | -7.3 Million | -5.26 Million | 583 Thousand | 409 Thousand | -1.84 Million | 231 Thousand |
| Net Income | -7.27 Million | -5.33 Million | 548 Thousand | 362 Thousand | -1.97 Million | 128 Thousand |
| Earnings Per Share Basic | -0.54 | -0.39 | 0.04 | 0.03 | -0.17 | 0.01 |
| Earnings Per Share Diluted | -0.54 | -0.39 | 0.04 | 0.02 | -0.17 | 0.01 |
| Weighted Average Shares Outstanding | 13.54 Million | 13.54 Million | 13.19 Million | 13.13 Million | 11.84 Million | 11.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.54 Million | 13.54 Million | 14.15 Million | 14.57 Million | 11.84 Million | 14.09 Million |
| Gross Margin | 0.41 | 0.45 | 0.52 | 0.48 | 0.47 | 0.47 |
| EBIT Margin | -0.10 | -0.03 | 0.05 | 0.04 | -0.01 | 0.03 |
| Profit Margin | -0.15 | -0.10 | 0.01 | 0.01 | -0.06 | 0.00 |
| EBITDA | -5.05 Million | -2.06 Million | 2.23 Million | 366 Thousand | -735 Thousand | 876 Thousand |
| Earnings Before Tax Margin | -0.15 | -0.08 | 0.01 | 0.01 | -0.05 | 0.01 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 14 Million | 50.15 Million | 12.01 Million | 11.57 Million | 12.56 Million | 53.87 Million |
| Cost of Revenue | 7.25 Million | 29.4 Million | 7.84 Million | 6.61 Million | 7.68 Million | 29.53 Million |
| Gross Profit | 6.75 Million | 20.75 Million | 4.17 Million | 4.95 Million | 4.87 Million | 24.33 Million |
| Operating Expenses | 6.58 Million | 27.67 Million | 6.74 Million | 6.91 Million | 7.42 Million | 28.78 Million |
| Selling, General and Administrative Expenses | 4.53 Million | - | 4.56 Million | 4.39 Million | 4.63 Million | - |
| Research and Development Expenses | 2.04 Million | - | 2.18 Million | 2.51 Million | 2.79 Million | - |
| Other Expenses | 81 Thousand | 48 Thousand | 58 Thousand | -105 Thousand | 14 Thousand | -11 Thousand |
| Cost and Expenses | 13.83 Million | 57.07 Million | 14.59 Million | 13.52 Million | 15.11 Million | 58.31 Million |
| Operating Income | 164 Thousand | -6.92 Million | -2.57 Million | -1.95 Million | -2.55 Million | -4.44 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -82 Thousand | -32 Thousand | 11 Thousand | 11 Thousand | 28 Thousand | 68 Thousand |
| Earnings before Tax | -191 Thousand | -7.3 Million | -2.51 Million | -2.06 Million | -2.53 Million | -5.26 Million |
| Net Income | -109 Thousand | -7.27 Million | -2.53 Million | -2.07 Million | -2.56 Million | -5.33 Million |
| Earnings Per Share Basic | -0.01 | - | -0.19 | -0.15 | -0.19 | - |
| Earnings Per Share Diluted | -0.01 | - | -0.19 | -0.15 | -0.19 | - |
| Weighted Average Shares Outstanding | 13.59 Million | 13.54 Million | 13.59 Million | 13.49 Million | 13.5 Million | 13.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.59 Million | 13.54 Million | 13.59 Million | 13.49 Million | 13.5 Million | 13.54 Million |
| Gross Margin | 0.48 | 0.41 | 0.35 | 0.43 | 0.39 | 0.45 |
| EBIT Margin | 0.04 | - | -0.11 | -0.13 | -0.17 | - |
| Profit Margin | -0.01 | -0.15 | -0.21 | -0.18 | -0.20 | -0.10 |
| EBITDA | 621 Thousand | - | -1.31 Million | -1.47 Million | -2.1 Million | - |
| Earnings Before Tax Margin | 0.01 | -0.14 | -0.21 | -0.17 | -0.20 | -0.08 |
7701
ACR
5388
MCDS
3580
VOLLF